Active Interconnection Study definition

Active Interconnection Study has the meaning set forth in Section 4.6(a) of the BioMAT Tariff. “Affiliate” means, with respect to a Party, any entity that, directly or indirectly, through one or more

Examples of Active Interconnection Study in a sentence

  • Category 3 Projects that do not have an Active Interconnection Study at the time the BioMAT PPA is executed shall submit a new Interconnection Study application within 30 days of executing the BioMAT PPA.

  • Provided all other requirements are met, Category 3 Projects without an Active Interconnection Study are eligible to participate in the BioMAT queue, provided the Applicant has provided a cash deposit as described in Section E.2(b) of this Schedule.

  • Category 3 Projects that do not T have an Active Interconnection Study at the time the BioMAT PPA is executed shall submit a N new Interconnection Study application within 30 days of executing the BioMAT PPA.

  • An Applicant’s Interconnection Study must have an active interconnection queue number in N SDG&E’s public interconnection queue (Active Interconnection Study) in order for the Applicant to be eligible to participate and remain in the BioMAT queue, with the exception of Applicants with Category 3 Projects.

  • An Applicant’s Interconnection Study must have an active interconnection queue number in SDG&E’s public interconnection queue (Active Interconnection Study) in order for the Applicant to be eligible to participate and remain in the BioMAT queue, with the exception of Applicants with Category 3 Projects.

  • Category 3 Deposit: Applicants submitting PPRs for Category 3 Projects without an Active Interconnection Study from SDG&E’s public interconnection queue, or those who subsequently withdraw their Active Interconnection Sudy after submitting a PPR, must pay a deposit equal to three times the System Impact Study’s Detailed Deposit amount as described in SDG&E’s Electric Rule No. 21 Tariff.

  • An Applicant’s Interconnection Study must have an active interconnection queue number in PG&E’s public wholesale distribution queue or the public CAISO interconnection queue (Active Interconnection Study) in order for the Applicant to be eligible to participate and remain in the BioMAT queue, with the exception of Applicants with Category 3 Projects.

  • Applicants submitting PPRs for Category 3 Projects without an Active N Interconnection Study from SDG&E’s public interconnection queue, or those who subsequently withdraw their Active Interconnection Study after submitting a PPR, must pay a deposit equal tothree times the System Impact Study’s Detailed Deposit amount as described in SDG&E’s Electric Rule No. 21 Tariff.

  • Expected COD: No later than thirty-six (36) months from execution date of the BioMAT PPA, or within thirty-six (36) months of the Interconnection Study Completion Date for Category 3 Projects that do not have an Active Interconnection Study at the time the BioMAT PPA is executed, as described in Section 4.6.b.

  • Provided all other requirements are met, Category 3 Projects that no longer have an Active Interconnection Study shall remain eligible to participate in the BioMAT queue, provided the Applicant has provided a cash deposit as described in Section 5.2(b) of this Schedule.

Related to Active Interconnection Study

  • Interconnection Study means any of the studies defined in the CAISO Tariff or, if applicable, any distribution provider’s tariff that reflect the methodology and costs to interconnect the Project to the Participating Transmission Owner’s electric grid.

  • Interconnection Studies means the Interconnection Feasibility Study, the System Impact Study, and the Facilities Study described in Tariff, Part IV and Tariff, Part VI. Interface Pricing Point:

  • Interconnection Feasibility Study means either a Generation Interconnection Feasibility Study or Transmission Interconnection Feasibility Study.

  • Generation Interconnection Feasibility Study means a study conducted by the Transmission Provider (in coordination with the affected Transmission Owner(s)) in accordance with Tariff, Part IV, section 36.2.

  • Optional Interconnection Study means a sensitivity analysis of an Interconnection Request based on assumptions specified by the Interconnection Customer in the Optional Interconnection Study Agreement.

  • Generation Interconnection Facilities Study means a Facilities Study related to a Generation Interconnection Request.

  • Optional Interconnection Study Agreement means the form of agreement for preparation of an Optional Interconnection Study, as set forth in Tariff, Attachment N-3. Part I:

  • Interconnection Point means the point(s) of connection(s) at which the project is connected to the grid i.e. it shall be at 11 / 22 kV bus bar level of substation of MSEDCL.

  • Development Site means any parcel or lot on which exists or which is intended for building development other than the following:

  • INTER-CONNECTION POINT/ DELIVERY/ METERING POINT means a single point at 220kV or above, where the power from the Project(s) is injected into the identified ISTS Substation (including the dedicated transmission line connecting the Projects with the substation system) as specified in the RfS document. Metering shall be done at this interconnection point where the power is injected into. For interconnection with grid and metering, the WPDs shall abide by the relevant CERC/ SERC Regulations, Grid Code and Central Electricity Authority (Installation and Operation of Meters) Regulations, 2006 as amended and revised from time to time.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Signaling Transfer Point (“STP”) means a signaling point that performs message routing functions and provides information for the routing of messages between signaling points within or between CCIS networks. An STP transmits, receives and processes CCIS messages.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Reference Interconnection Offer or “RIO” means a document published by a service provider specifying terms and conditions on which the other service provider may seek interconnection with such service provider;

  • Interconnection Service means the physical and electrical interconnection of the Customer Facility with the Transmission System pursuant to the terms of Tariff, Part IV and Tariff, Part VI and the Interconnection Service Agreement entered into pursuant thereto by Interconnection Customer, the Interconnected Transmission Owner and Transmission Provider. Interconnection Service Agreement:

  • Transmission Owner Interconnection Facilities means all Interconnection Facilities that are not Customer Interconnection Facilities and that, after the transfer under Tariff, Attachment P, Appendix 2, section 5.5 to the Interconnected Transmission Owner of title to any Transmission Owner Interconnection Facilities that the Interconnection Customer constructed, are owned, controlled, operated and maintained by the Interconnected Transmission Owner on the Interconnected Transmission Owner’s side of the Point of Interconnection identified in appendices to the Interconnection Service Agreement and to the Interconnection Construction Service Agreement, including any modifications, additions or upgrades made to such facilities and equipment, that are necessary to physically and electrically interconnect the Customer Facility with the Transmission System or interconnected distribution facilities. Transmission Provider: The “Transmission Provider” shall be the Office of the Interconnection for all purposes, provided that the Transmission Owners will have the responsibility for the following specified activities:

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Interconnection is As Defined in the Act.

  • Generation Interconnection Customer means an entity that submits an Interconnection Request to interconnect a new generation facility or to increase the capacity of an existing generation facility interconnected with the Transmission System in the PJM Region. Generation Interconnection Request:

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Interconnector means equipment used to link the electricity system of the State to electricity systems outside of the State;

  • Interconnection Customer means a Generation Interconnection Customer and/or a Transmission Interconnection Customer.

  • Interconnection Activation Date means the date that the construction of the joint facility Interconnection arrangement has been completed, trunk groups have been established, joint trunk testing is completed and trunks have been mutually accepted by the Parties.

  • interconnected system means a number of transmission and distribution systems linked together by means of one or more interconnectors;